CA2237335C - Utilisation therapeutique des inhibiteurs de la cholinesterase contre la xerostomie - Google Patents

Utilisation therapeutique des inhibiteurs de la cholinesterase contre la xerostomie Download PDF

Info

Publication number
CA2237335C
CA2237335C CA002237335A CA2237335A CA2237335C CA 2237335 C CA2237335 C CA 2237335C CA 002237335 A CA002237335 A CA 002237335A CA 2237335 A CA2237335 A CA 2237335A CA 2237335 C CA2237335 C CA 2237335C
Authority
CA
Canada
Prior art keywords
xerostomia
treatment
cholinesterase inhibitor
topical administration
oral mucosa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002237335A
Other languages
English (en)
Other versions
CA2237335A1 (fr
Inventor
Jorgen Ekstrom
Herbert Helander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CALABAR AB
Original Assignee
CALABAR AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9504267A external-priority patent/SE9504267D0/xx
Application filed by CALABAR AB filed Critical CALABAR AB
Publication of CA2237335A1 publication Critical patent/CA2237335A1/fr
Application granted granted Critical
Publication of CA2237335C publication Critical patent/CA2237335C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La présente invention concerne l'utilisation d'un inhibiteur de la cholinestérase dans la fabrication d'un médicament destiné à l'application locale en thérapie contre la xérostomie.
CA002237335A 1995-11-29 1996-11-25 Utilisation therapeutique des inhibiteurs de la cholinesterase contre la xerostomie Expired - Fee Related CA2237335C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9504267A SE9504267D0 (sv) 1995-11-29 1995-11-29 New therapeutic use
SE9504267-7 1995-11-29
PCT/SE1996/001531 WO1997019685A1 (fr) 1995-11-29 1996-11-25 Utilisation therapeutique des inhibiteurs de la cholinesterase contre la xerostomie

Publications (2)

Publication Number Publication Date
CA2237335A1 CA2237335A1 (fr) 1997-06-05
CA2237335C true CA2237335C (fr) 2007-06-05

Family

ID=38137603

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002237335A Expired - Fee Related CA2237335C (fr) 1995-11-29 1996-11-25 Utilisation therapeutique des inhibiteurs de la cholinesterase contre la xerostomie

Country Status (1)

Country Link
CA (1) CA2237335C (fr)

Also Published As

Publication number Publication date
CA2237335A1 (fr) 1997-06-05

Similar Documents

Publication Publication Date Title
US5157025A (en) Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
DE69121464T2 (de) Verfahren zur Verhütung, Stabilisierung oder Verursachung des Zurückgangs von Atherosklerose durch Anwendung einer Mischung von einem Cholesterol-vermindernden Arzneimittel mit einem ACE-Inhibitor
DE69323213T2 (de) Kombination eines Hemmers der Cholesterin-Biosynthese und eines beta-laktamischem Hemmers der Cholesterinabsorption
IL149496A (en) Pharmaceutical compositions and their use in the treatment of the gastrointestinal tract
US5741805A (en) Controlled release pilocarpine delivery system
Felpel A review of pharmacotherapeutics for prosthetic dentistry: Part I
KR100609381B1 (ko) 인지 장애 치료방법
US5962503A (en) Use of cholinesterase inhibitors in the treatment of xerostomia
US6426085B1 (en) Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
JPH10152426A (ja) 漢方薬入り口腔衛生剤
CA2237335C (fr) Utilisation therapeutique des inhibiteurs de la cholinesterase contre la xerostomie
RU2242963C2 (ru) Мукоадгезивная композиция для лечения стоматологических заболеваний и способ ее полученияя
US5387614A (en) Use of sigma receptor ligands as salivary gland stimulants
US6902738B2 (en) Topical oral dosage forms containing bismuth compounds
HK1127994A (en) The use of a cholinesterase inhibitor in the treatment of xerostomia
US6372784B1 (en) Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
JPH0637379B2 (ja) 歯周疾患治療用外用剤
JP3154285B2 (ja) コラゲナーゼ活性阻害剤
EP0659077A1 (fr) Systeme d'administration de la pilocarpine a liberation controlee
JPH10120592A (ja) メニエール病乃至メニエール症候群治療剤
US20250195566A1 (en) Oral pharmaceutical composition for preventing and/or treating diseases of the soft and hard tissues surrounding the tooth in the oral cavity
EP0879035A1 (fr) Composes renfermant du bismuth sous forme de doses a application locale
HK1129595B (en) Combination of alpha-2 receptor agonist (clonidin) and an anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea
HK1129595A1 (zh) α2受体激动剂(可乐定)与抗毒蕈碱药(奥昔布宁)联合用於治疗流涎
FR2771006A1 (fr) Association de principes actifs pour le traitement de la demence senile du type alzheimer

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed